394 related articles for article (PubMed ID: 25941873)
1. Cancer incidence in people living with HIV/AIDS in Israel, 1981-2010.
Zohar M; Micha B
AIDS Res Hum Retroviruses; 2015 Sep; 31(9):873-81. PubMed ID: 25941873
[TBL] [Abstract][Full Text] [Related]
2. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
3. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
[TBL] [Abstract][Full Text] [Related]
4. Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea.
Lee SO; Lee JE; Lee S; Lee SH; Kang JS; Son H; Lee H; Kim J
Sci Rep; 2022 Jun; 12(1):9974. PubMed ID: 35705675
[TBL] [Abstract][Full Text] [Related]
5. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
6. Burden of non-AIDS-defining and non-virus-related cancers among HIV-infected patients in the combined antiretroviral therapy era.
Albini L; Calabresi A; Gotti D; Ferraresi A; Festa A; Donato F; Magoni M; Castelli F; Quiros-Roldan E
AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1097-104. PubMed ID: 23581483
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis incidence in HIV/AIDS patients in Israel, 1983-2010.
Mor Z; Lidji M; Cedar N; Grotto I; Chemtob D
PLoS One; 2013; 8(11):e79691. PubMed ID: 24278157
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.
Hernández-Ramírez RU; Shiels MS; Dubrow R; Engels EA
Lancet HIV; 2017 Nov; 4(11):e495-e504. PubMed ID: 28803888
[TBL] [Abstract][Full Text] [Related]
9. Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.
Calabresi A; Ferraresi A; Festa A; Scarcella C; Donato F; Vassallo F; Limina R; Castelli F; Quiros-Roldan E;
HIV Med; 2013 Sep; 14(8):481-90. PubMed ID: 23560682
[TBL] [Abstract][Full Text] [Related]
10. Incidence of first and second primary cancers diagnosed among people with HIV, 1985-2013: a population-based, registry linkage study.
Hessol NA; Whittemore H; Vittinghoff E; Hsu LC; Ma D; Scheer S; Schwarcz SK
Lancet HIV; 2018 Nov; 5(11):e647-e655. PubMed ID: 30245004
[TBL] [Abstract][Full Text] [Related]
11. Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study.
Zhu K; Xu Q; Ma Y; Li P; Jia H; Jiang Q; Wang Y; Wu Z; Wang D; Guo H; Jin Y
J Med Virol; 2022 Oct; 94(10):4975-4982. PubMed ID: 35710693
[TBL] [Abstract][Full Text] [Related]
12. Healthcare costs associated with antiretroviral adherence among medicaid patients.
Pruitt Z; Robst J; Langland-Orban B; Brooks RG
Appl Health Econ Health Policy; 2015 Feb; 13(1):69-80. PubMed ID: 25403718
[TBL] [Abstract][Full Text] [Related]
13. Knowledge and attitudes regarding HIV/AIDS and antiretroviral therapy among patients at a Nigerian treatment clinic.
Olowookere SA; Fatiregun AA; Adewole IF
J Infect Dev Ctries; 2012 Nov; 6(11):809-16. PubMed ID: 23277507
[TBL] [Abstract][Full Text] [Related]
14. Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study.
Raffetti E; Albini L; Gotti D; Segala D; Maggiolo F; di Filippo E; Saracino A; Ladisa N; Lapadula G; Fornabaio C; Castelnuovo F; Casari S; Fabbiani M; Pierotti P; Donato F; Quiros-Roldan E;
BMC Public Health; 2015 Mar; 15():235. PubMed ID: 25884678
[TBL] [Abstract][Full Text] [Related]
15. Population-based study of malignancies and HIV infection among injecting drug users in a New York City methadone treatment program, 1985-1991.
Gachupin-Garcia A; Selwyn PA; Budner NS
AIDS; 1992 Aug; 6(8):843-8. PubMed ID: 1329849
[TBL] [Abstract][Full Text] [Related]
16. Causes of death and mortality trends of all individuals reported with HIV/AIDS in Israel, 1985-2010.
Mor Z; Sheffer R; Chemtob D
J Public Health (Oxf); 2018 Mar; 40(1):56-64. PubMed ID: 28633458
[TBL] [Abstract][Full Text] [Related]
17. Determination of medication adherence and related factors among people living with HIV/AIDS in a Turkish university hospital.
Ceylan E; Koç A; İnkaya AÇ; Ünal S
Turk J Med Sci; 2019 Feb; 49(1):198-205. PubMed ID: 30764598
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
19. [Key quality indicators of the China Comprehensive AIDS Response 2008 - 2011 Program].
Wu D; Zhang H; Yao XL; Cui Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Dec; 46(12):1095-8. PubMed ID: 23363966
[TBL] [Abstract][Full Text] [Related]
20. Mortality among people living with HIV/AIDS with non-small-cell lung cancer in the modern HAART Era.
Smith DM; Salters KA; Eyawo O; Franco-Villalobos C; Jabbari S; Wiseman SM; Press N; Montaner JSG; Man SFP; Hull M; Hogg RS
AIDS Care; 2018 Jul; 30(7):936-942. PubMed ID: 29411625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
